[ORGANIZATION]
URPL
Featured in 2 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
247 clusters · 895 sources · last updated
Latest: GLP-1 medications transform obesity treatment approach
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Also covered in
-
URPL experts reject over-the-counter status for sumatriptan
[HEALTH] · 2 sources ·